Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate BrainsWay Ltd. before investing.

In this article, we go over a few key elements for understanding BrainsWay Ltd.’s stock price such as:

• BrainsWay Ltd.’s current stock price and volume
• Why BrainsWay Ltd.’s stock price changed recently
• Upgrades and downgrades for BWAY from analysts
• BWAY’s stock price momentum as measured by its relative strength

About BrainsWay Ltd. (BWAY)

Before we jump into BrainsWay Ltd.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Want to learn more about BrainsWay Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about BrainsWay Ltd..

BrainsWay Ltd.’s Stock Price as of Market Close

As of April 17, 2026, 4:00 PM, CST, BrainsWay Ltd.’s stock price was $15.810.

BrainsWay Ltd. is up 3.13% from its previous closing price of $15.330.

During the last market session, BrainsWay Ltd.’s stock traded between $15.210 and $16.040. Currently, there are approximately 39.15 million shares outstanding for BrainsWay Ltd..

BrainsWay Ltd.’s price-earnings (P/E) ratio is currently at 123.5, which is high compared to the Health Care Equipment & Supplies industry median of 30.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

BrainsWay Ltd. Stock Price History

BrainsWay Ltd.’s (BWAY) price is currently up 18.96% so far this month.

During the month of April, BrainsWay Ltd.’s stock price has reached a high of $16.240 and a low of $12.040.

Over the last year, BrainsWay Ltd. has hit prices as high as $16.240 and as low as $3.920. Year to date, BrainsWay Ltd.’s stock is up 66.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused BrainsWay Ltd. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 17, 2026, there were 0 analysts who downgraded BrainsWay Ltd.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate BrainsWay Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on BrainsWay Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

BrainsWay Ltd.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about BrainsWay Ltd. (BWAY) by visiting AAII Stock Evaluator.

Relative Price Strength of BrainsWay Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 17, 2026, BrainsWay Ltd. has a weighted four-quarter relative price strength of 30.22%, which translates to a Momentum Score of 94 and is considered to be Very Strong.

Want to learn more about how BrainsWay Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

BrainsWay Ltd. Stock Price: Bottom Line

As of April 17, 2026, BrainsWay Ltd.’s stock price is $15.810, which is up 3.13% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like BrainsWay Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.